PD DR. CARSTEN RUDOLPH
Chief Executive Officer ad interim
- Inventor of SNIM® RNA technology
- Expertise in lung delivery
- 15 Patents / Applications > 60 publications
- Academic at LMU Munich
PD DR. CARSTEN RUDOLPH
Chief Scientific Officer
- Inventor of SNIM® RNA technology
- Expertise in lung delivery
- 15 Patents / Applications > 60 publications
- Academic at LMU Munich
PROF. DR. CHRISTIAN PLANK
Chief Technology Officer
- Expertise in targeted drug delivery: Nucleic acids, cancer, regenerative medicine
- 12 Patents / Applications > 90 publications
- Professor at TU Munich
THOMAS LANGENICKEL, M.D
Chief Medical Officer
- More than 15 years of experience in clinical development and translational medicine in cardiovascular and respiratory disease areas
- Previously Executive Director and Head of Respiratory Profiling at Novartis AG
- M.D. and Ph.D. at Humboldt University of Berlin
- Clinical Pharmacology and Internal Medicine/Cardiology at the MDC and the Charité in Berlin
- Post-doctoral fellowship at the National Heart, Lung and Blood Institute in Bethesda, USA
THOMAS LANGENICKEL, M.D
Chief Medical Officer
- More than 15 years of experience in clinical development and translational medicine in cardiovascular and respiratory disease areas
- Previously Executive Director and Head of Respiratory Profiling at Novartis AG
- M.D. and Ph.D. at Humboldt University of Berlin
- Clinical Pharmacology and Internal Medicine/Cardiology at the MDC and the Charité in Berlin
- Post-doctoral fellowship at the National Heart, Lung and Blood Institute in Bethesda, USA
